Publikace UTB
Repozitář publikační činnosti UTB

Metabolic syndrome and NAFLD in a social reintegration facility environment-project results

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title Metabolic syndrome and NAFLD in a social reintegration facility environment-project results en
dc.contributor.author Belovičová, Mária
dc.contributor.author Popovičová, Mária
dc.contributor.author Babečka, Jozef
dc.contributor.author Snopek, Petr
dc.relation.ispartof Clinical Social Work and Health Intervention
dc.identifier.issn 2222-386X Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2021
utb.relation.volume 12
utb.relation.issue 5
dc.citation.spage 59
dc.citation.epage 65
dc.type article
dc.language.iso en
dc.publisher Int Scientific Group Applied Preventive Medicine I-GAP EV
dc.identifier.doi 10.22359/cswhi_12_5_09
dc.relation.uri https://clinicalsocialwork.eu/wp-content/uploads/2021/12/cswhi_05_2021_09_belovicova.pdf
dc.subject metabolic syndrome en
dc.subject non-alcoholic fatty liver disease en
dc.subject social reintegration facility en
dc.subject fibrosis indexes en
dc.subject transient elastography en
dc.description.abstract Introduction: Metabolic syndrome (MS) is a metabolic disease characterized by a simultaneous occurrence of several risk factors (RF) for the development of cardiovascular diseases. NAFLD - Non-alcoholic fatty liver disease - is characterized by the presence of hepatic steatosis, i.e. excessive accumulation of fat in liver tissue that is associated with insulin resistance. Objectives: To determine the presence of MS and liver diseases in clients of the Social Reintegration Facility in Zakovce. The project "Screening of liver diseases in Social Reintegration Facility" ran from 1/2020 to 10/2020. It was carried out within the institutional project of the St. Elizabeth University of Health and Social Sciences (VSZaSP sv. Alzbety) and the Slovak Society of Practical Obesitology (SSPO). Participants and methods: A total of 229 clients and employees of the Social Reintegration Facility of the Institute of Christ the High Priest in Zakovce: 188 clients (82%); 41 employees (18%). Men made up 63% of the sample (145); women 37% (84). The mean age of the clients was 51.4 years, the mean length of their stay in the facility was 5.87 years. We clinically examined the clients and employees, and we collected venous and capillary blood. We examined the stiffness of liver tissue with transient elastography, and we used a special CAP software to quantify the presence of steatosis. Results: In the group of examined clients and employees of the Social Reintegration Facility in Zakovce, we were in particular looking for the presence of liver diseases. However, we also found the presence of other diseases of civilization that have a statistically significant effect on the indicators of MS, FLI, NFS, APRI, FIB-4, FS and CAP. Other research results are described by the authors in more detail in the article. Conclusion: NAFLD is considered to be a slowly progressing chronic liver disease in both, adults and children. Besides taking care of our outpatient clinics patients, we should not forget about clients of the social reintegration facilities, in whom - due to the presence of several risk factors the incidence of liver diseases and other diseases of civilization is even higher compared to the general population. en
utb.faculty Faculty of Humanities
dc.identifier.uri http://hdl.handle.net/10563/1010877
utb.identifier.obdid 43883093
utb.identifier.wok 000754375000010
utb.source J-wok
dc.date.accessioned 2022-03-15T22:10:59Z
dc.date.available 2022-03-15T22:10:59Z
dc.rights Attribution 4.0 International
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.rights.access openAccess
utb.ou Department of Health Care Sciences
utb.contributor.internalauthor Snopek, Petr
utb.fulltext.affiliation M. Belovicova (Maria Belovicova) 1,2,3, M. Popovicova (Maria Popovicova) 1, J. Babecka (Jozef Babecka) 4, P. Snopek (Petr Snopek) 5,6 1 St. Elizabeth University of Health and Social Sciences, Bratislava – Teacher, SK. 2 Internal Clinic for Liver Disease Diagnosis and Treatment, Remedium s. r. o., SK. 3 Slovak Society of Practical Obesitology (SSPO), Bardejov, SK. 4 Catholic University in Ruzomberok, Faculty of Health, Ruzomberok – teacher, SK. 5 Tomas Bata University in Zlin, Faculty of Humanities, Department of Health Care Sciences - Professional Assistant, CR. 6 Hospital in Zlin, Zlin, CR. E-mail address: mriab9@gmail.com Reprint address: Maria Belovicova St. Elizabeth University of Health and Social Sciences, Bratislava Nam. 1. maja 1 811 06 Bratislava
utb.fulltext.dates -
utb.fulltext.references 1. BELOVICOVA M, VANSAC P (2009) Selected aspects of medical and social care for long-term ill persons. Krakow: Society of the Slovaks in Poland, 2019, p.153. ISBN 978-83-81111-109-6. 2. BELOVICOVA M (2019) Non-alcoholic fatty liver disease and its impact on public health. Krakow: Society of the Slovaks in Poland, 2019, p. 96. ISBN 978-83-8111-142-3. 3. ORAVEC S, BLAZICEK P, KUCERA M (2020) Importance of determining lipoprotein subpopulations in metabolic syndrome. New possibilities for cardiovascular risk assessment in obese patients. 324-341. In: Proceedings of the Days of Practical Obesitology and Metabolic Syndrome 16.-18.07.2020. Collegium Humanum – Warsaw Menagement University, Warszawa 2020, p. 440. ISBN 978-83-958245-0-0. 4. HOLOMAN J, SZANTOVA M, ZIMA M, KOLLER T, FABRYOVA L (2017) Non-alcoholic fatty liver disease - standard diagnostic and therapeutic procedure. 63. Methodical sheet of rational pharmacotherapy. 2017; p. 20 (1-2). 5. EHRMANN J, AIGLOVA K, VRZALOVA D, AIGLOVA R, KONECNY M, PROCHAZKA V (2017) Extrahepatic manifestations of NAFLD (non-alcoholic fatty liver disease, non-alcoholic liver disease in steatosis). Is there a causal link? Internal Med. 2017; 19(2): pp. 72–77. ISSN 1803-5256 (online). 6. JALAN R, DE CHIARA F, BALASUBRAMANIYAN V et al. (2016) Ammonia preduces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. In: J Hepatology 2016; 64: pp. 823-833. ISSN 0168-8278. 7. DE LEDINGHHEN V et al. (2012) Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. In: Liver Int. 2012; 32(6): pp. 911-918. ISSN:1478-3231 (online). 8. KARLAS T et al. (2014) Non-invasive asessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. In: Plos One 2014; 9(3) e91987 ISSN. 9. VERNON G, BARANOVA A, YOUNOSSI ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ter. 2011; 34: 274-285.ISSN:1365-2036 (Online). 10. LEITE NC, VILLEA-NOGUERIA CA, CARDOSO CRL, SALLES GF (2014) Nonalcoholic fatty liver disease and diabetes. From pathophysiological interplay to diagnosis and treatment. WJG. 2014; 14: 8377/8392. ISSN 2219-2840 (online). 11. DRAZILOVA S (2020) Non-alcoholic fatty liver disease. pp. 249.265. In: Drazilova, S., Gombosova, L., Janicko, M., Skladany, L., Veseliny, E. Selected chapters from gastroenterology hepatology. Kosice: UPJS LF, 2020, p. 284. ISBN 978-80-8152-838-5 (e-publication) 12. EASL-EAS-EASO (2016) Clinical Practice Guidelines: For the management of Non-Alcoholic Fatty Liver Disease. J Hep.2016; http://dx.doi.org/10.2016/j.jhep.2015.11.004. 13. BELOVICOVA M (2018) Selected liver diseases and their impact on public health. Bardejov: SSPO, 2018, p. 159. ISBN 978-80-971460-6-1. 14. NIEDERAU C (2015) NAFLD and NASH. s. 507-529. In: Mauss, S., Berg, T., Rochstroh, J. et al.: Hepatology. A Clinical Textbook. Flying Publisher 2015, 6th edition, p. 650. ISBN 978-3-924774-92-9. 15. BRUHA R (2015) Screening for liver damage in patients with type 2 diabetes mellitus. In: Gastroent hepatol 2015; 69(4): pp. 365-367. ISSN: 1804-7874. 16. BELOVICOVA M, POPOVICOVA M, VANSAC P (2021) The impact of the Mediterranean diet on the health of the individual. Slovak Society of Practical Obesitology, 2021, p. 245. ISBN 978-80-971460-8-5 17. HOLOMAN J, SZANTOVA M, ZIMA M, SLOBODOVA L (2016) Management of non-alcoholic fatty liver disease. Via pract., 2016, 13(5): pp. 179 -186. ISSN 1339-424X (Online). 18. BELOVICOVA M, MASTEROVA V (2016) Non-alcoholic fatty liver disease - severe comorbidity of diabetes. Forum Diab 2016; 5(1): pp. 45-48. ISSN 1805–3807. 19. SPICAK, J. Covid-19 and hepatogastroenterology. Gastroent Hepatol 2020; 74(5): 415-423. ISSN 1804-7874.
utb.fulltext.sponsorship -
utb.wos.affiliation [Belovicova, Maria; Popovicova, Maria] St Elizabeth Univ Hlth & Social Sci, Nam 1 Maja 1, Bratislava 81106, Slovakia; [Belovicova, Maria] Remedium s r o, Internal Clin Liver Dis Diag & Treatment, Bardejov, Slovakia; [Belovicova, Maria] Slovak Soc Pract Obesitol SSPO, Bardejov, Slovakia; [Babecka, Jozef] Catholic Univ Ruzomberok, Fac Hlth, Ruzomberok, Slovakia; [Snopek, Petr] Tomas Bata Univ, Dept Hlth Care Sci, Fac Humanities, Zlin, Czech Republic; [Snopek, Petr] Hosp Zlin, Zlin, Czech Republic
utb.fulltext.projects -
utb.fulltext.faculty Faculty of Humanities
utb.fulltext.ou Department of Health Care Sciences
Find Full text

Soubory tohoto záznamu

Zobrazit minimální záznam

Attribution 4.0 International Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Attribution 4.0 International